Novartis Bioventures Ltd, Ten Percent Owner at Eledon Pharmaceuticals, holds 4.49M shares in Eledon Pharmaceuticals (Ticker: ELDN), holds 1.87M shares in Kineta (Ticker: KA), holds 1.18M shares in AKOUOS (Ticker: AKUS). Most recently, Novartis Bioventures Ltd Sold ― shares of Eledon Pharmaceuticals on Jul 17, 2015 for an estimated value of 50.82K.
What was Novartis Bioventures Ltd’s latest transaction?
Novartis Bioventures Ltd latest transaction was an Informative Sell of $50.82K.
What was Novartis Bioventures Ltd's most profitable transaction?
Novartis Bioventures Ltd’s most profitable transaction was an Informative Buy of EIGRQ stock on February 6, 2014. The return on the trade was 103.10%.
What is Novartis Bioventures Ltd's role in Eledon Pharmaceuticals?
Novartis Bioventures Ltd's role in Eledon Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.